Showing 5601-5610 of 9771 results for "".
- AIM at Melanoma Opens Melanoma Tissue Bank in the UShttps://practicaldermatology.com/news/aim-at-melanoma-opens-melanoma-tissue-bank-in-the-us/2459991/AIM at Melanoma celebrated the grand opening of the first branch of the International Melanoma Tissue Bank Consortium (IMTBC) at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center. The Pittsburgh site is one of six global locations of the consortium. These six institutions
- PALLAS Ti: Sapphire Solid State Laser Shows Similar Efficacy and Safety to 308nm Excimer Laser for Localized Vitiligohttps://practicaldermatology.com/news/pallas-tisapphire-solid-state-laser-shows-similar-efficacy-and-safety-to-308nm-excimer-laser-for-localized-vitiligo/2459953/A novel 311nm Titanium:Sapphire UV laser demonstrates comparable efficacy and safety when compared to 308nm excimer laser in the treatment of localized vitiligo, according to a study recently published in Lasers in Surgery and Medicine. Manufactured by
- Meet JOULE X and More New Offerings from Sciton at ASLMShttps://practicaldermatology.com/news/meet-joule-x-and-more-new-offerings-from-sciton-at-aslms/2459954/Sciton Inc. unveiled JOULE X and other new offerings at the annual American Society for Laser Medicine and Surgery Meeting in Denver, Colorado. An upgrade to the JOULE platform, JOULE X is the company’s latest multi-device platform. It work
- Now Available: neuLASH Professional and neuBROW Professionalhttps://practicaldermatology.com/news/now-available-neulash-professional-and-neubrow-professional/2459956/New from Skin Research Professional and Olive and Delmar, neuLASH PROFESSIONAL™ and neuBROW PROFESSIONAL™ are available in all new, next-generation, professional-strength formulations. neuLASH PROFESSIONAL™ is a peptide serum promoting longer-looking lashes and neuBROW PROFESS
- Lead Pharma Begins Phase I Trials with SAR441169 Candidate Treatment for Psoriasishttps://practicaldermatology.com/news/lead-pharma-to-begin-phase-i-trials-with-sar441169-candidate-treatment-for-psoriasis/2459962/Lead Pharma, a pharmaceutical company developing innovative medicines for the treatment of immunological and oncological indications, achieved a fourth milestone under its license & collaboration agreement with Sanofi, triggering an undisclosed milestone payment. The milestone payment is link
- Biofrontera Reports Positive Phase 3 Results with Ameluz for PDT of AKs on Extremities and Trunk/Neckhttps://practicaldermatology.com/news/biofrontera-reports-positive-phase-3-results-with-ameluz-for-pdt-of-aks-on-extremities-and-trunkneck/2459961/Results for the primary endpoint of Biofrontera AG's Phase 3 clinical trial evaluating the safety and efficacy of conventional photodynamic therapy (PDT) with Ameluz and the BF-RhodoLED lamp for the treatment of actinic keratoses (AK) on the extremities as well as the trunk and neck are posti
- Galderma Collaborates with Nespresso to Offer Patient Loyalty Incentive Programhttps://practicaldermatology.com/news/galderma-collaborates-with-nespresso-to-offer-patient-loyalty-incentive-program/2459968/Galderma Laboratories, L.P., recently teamed up with Nespresso to offer a new rewards program for patients who seek Restylane treatments from aesthetic professionals. With a qualifying purchase of Restylane dermal fillers, aesthetic professionals will receive a set of vouchers for complimentary N
- Dermira's Investigational AD Drug Performs Well in Phase 2b Trial, Shares Skyrockethttps://practicaldermatology.com/news/ready-for-phase-3-dermiras-investigational-ad-drug-performs-well-in-phase-2b-trial/2459969/All three doses of Dermira, Inc.’s lebrikizumab showed greater improvements in the Eczema Area and Severity Index in a new Phase 2b dose-ranging study of adults with moderate-to-severe atopic dermatitis, and shares of D
- History of Dermatology Society Names Samuel J. Zakon Awardeehttps://practicaldermatology.com/news/history-of-dermatology-society-names-samuel-j-zakon-awardee/2459972/Frederick C. Gaede, BA, MAS, has received the Samuel J. Zakon Award in the History of Dermatology for his article entitled “Henry Granger Piffard, MD and His Photogenic Pistol Cartridges.” The Award was announced at the forty-sixth annual meeting of the History of Dermatology Society
- New Mouse Model Validates How “Good” and “Bad” Bacteria Affect Acnehttps://practicaldermatology.com/news/new-mouse-model-validates-how-good-and-bad-bacteria-affect-acne/2459981/Researchers at University of California San Diego School of Medicine, Cedars-Sinai and UCLA have developed a new mouse model that closely resembles human acne by adding one new factor — a synthetic sebum. Researchers have long believed that Propionibacterium acnes causes ac